Literature DB >> 29016756

The electrocardiogram as a predictor of successful pharmacological cardioversion and progression of atrial fibrillation.

Stef Zeemering1, Theo A R Lankveld1,2, Pietro Bonizzi3, Ione Limantoro2, Sebastiaan C A M Bekkers2, Harry J G M Crijns2, Ulrich Schotten1.   

Abstract

Aims: Non-invasive characterization of atrial fibrillation (AF) substrate complexity based on the electrocardiogram (ECG) may improve outcome prediction in patients receiving rhythm control therapies for AF. Multiple parameters to assess AF complexity and predict treatment outcome have been suggested. A comparative study of the predictive performance of complexity parameters on response to therapy and progression of AF in a large patient population is needed to standardize non-invasive analysis of AF. Methods and results: A large variety of ECG complexity parameters were systematically compared in patients with recent onset AF undergoing pharmacological cardioversion (PCV) with flecainide. Parameters were computed on 10-s 12-lead ECGs of 221 patients before drug administration. The ability of ECG parameters to predict successful PCV and progression to persistent AF (mean follow-up 49 months) was evaluated and compared with common clinical predictors. Optimal prediction performance of successful PCV using only one ECG parameter was low, using dominant atrial frequency [lead II, receiver operating area under curve (AUC) 0.66, 95% confidence interval [0.64-0.67]], but the optimal combination of several ECG parameters strongly improved predictive performance (AUC 0.78 [0.76-0.79]). While predictive value of the optimal combination of clinical predictors was low (AUC 0.68 [0.66-0.70], using right atrial volume and weight), adding ECG parameters strongly increased performance (AUC 0.81 [0.79-0.82], P < 0.001). Interestingly, higher dominant frequency and higher f-wave amplitude were associated with increased risk of progression to persistent AF during follow-up.
Conclusion: Assessment of AF complexity from 12-lead ECGs significantly improves prediction of successful PCV and progression to persistent AF compared with common clinical and echocardiographic predictors.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29016756     DOI: 10.1093/europace/eux234

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  5 in total

1.  Noninvasive Assessment of Atrial Fibrillation Complexity in Relation to Ablation Characteristics and Outcome.

Authors:  Marianna Meo; Thomas Pambrun; Nicolas Derval; Carole Dumas-Pomier; Stéphane Puyo; Josselin Duchâteau; Pierre Jaïs; Mélèze Hocini; Michel Haïssaguerre; Rémi Dubois
Journal:  Front Physiol       Date:  2018-07-17       Impact factor: 4.566

2.  Extended ECG Improves Classification of Paroxysmal and Persistent Atrial Fibrillation Based on P- and f-Waves.

Authors:  Matthias Daniel Zink; Rita Laureanti; Ben J M Hermans; Laurent Pison; Sander Verheule; Suzanne Philippens; Nikki Pluymaekers; Mindy Vroomen; Astrid Hermans; Arne van Hunnik; Harry J G M Crijns; Kevin Vernooy; Dominik Linz; Luca Mainardi; Angelo Auricchio; Stef Zeemering; Ulrich Schotten
Journal:  Front Physiol       Date:  2022-03-04       Impact factor: 4.566

3.  In-silico drug trials for precision medicine in atrial fibrillation: From ionic mechanisms to electrocardiogram-based predictions in structurally-healthy human atria.

Authors:  Albert Dasí; Aditi Roy; Rafael Sachetto; Julia Camps; Alfonso Bueno-Orovio; Blanca Rodriguez
Journal:  Front Physiol       Date:  2022-09-15       Impact factor: 4.755

4.  Novel spatiotemporal processing tools for body-surface potential map signals for the prediction of catheter ablation outcome in persistent atrial fibrillation.

Authors:  Anna McCann; Adrian Luca; Patrizio Pascale; Etienne Pruvot; Jean-Marc Vesin
Journal:  Front Physiol       Date:  2022-09-29       Impact factor: 4.755

5.  A novel framework for noninvasive analysis of short-term atrial activity dynamics during persistent atrial fibrillation.

Authors:  Pietro Bonizzi; Olivier Meste; Stef Zeemering; Joël Karel; Theo Lankveld; Harry Crijns; Ulrich Schotten; Ralf Peeters
Journal:  Med Biol Eng Comput       Date:  2020-06-13       Impact factor: 2.602

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.